chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 31.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Poor quality sleep
Clinical narrative: Could not sleep well; Felt dry in mouth even after drinking water; cannot take food; Acid reflux was worsening, could not take food; Rapid heartbeat immediately after the injection; This is a spontaneous report from a contactable consumer, the patient. A 31-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 22Mar2021 at 14:00 (at the age of 31-year-old) as a single dose for COVID-19 immunisation. Medical history included acid reflux, gastroesophageal reflux disease (GERD). Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications were not reported. On 22Mar2021 at 14:00, the patient experienced rapid heartbeat immediately after the injection. Two days later, on 24Mar2021, the patient's acid reflux was worsening, could not take food. Three weeks later, on 12Apr2021, the patient experienced another rapid heartbeat and could not sleep well. The patient always felt dry in mouth even after drinking water. The events resulted in doctor or other healthcare professional office/clinic visit/emergency room/department or urgent care. Therapeutic measures were taken as a result of events, rapid heartbeat, acid reflux was worsening, could not take food, could not sleep well and felt dry in mouth even after drinking water and included treatment with medicines for acid reflux and EKG (electrocardiogram) was performed on an unknown date. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events rapid heartbeat, acid reflux was worsening, could not take food, could not sleep well and felt dry in mouth even after drinking water was not resolved at the time of this report.   No follow-up attempts are possible; information about lot number cannot be obtained. No further information is expected.
Age: 13.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Injection site pain, Pyrexia
Clinical narrative: Severe Pain In Left ArmFever Of 102.3Pain At Injection Site; fever; injection site pain; This is a spontaneous report from a contactable consumer, the patient. A 13-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 06Jun2021 at 12:30 (at the age of 13-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 16May2021 at 12:30 hours (at the age of 13-years-old) as a single dose for COVID-19 immunisation. Concomitant medications included montelukast sodium (SINGULAIR) once a day and ascorbic acid, pyridoxal phosphate, biotin, folic acid, colecalciferol, calcium pantothenate, ascorbyl palmitate, cocarboxylase, calcium citrate, tocopheryl acid succinate, calcium ascorbate, magnesium aspartate, betacarotene, manganese, molybdenum, chromium, copper, vanadium, iodine, selenium, mecobalamin, magnesium ascorbate, zinc gluconate, bioflavonoids nos, nicotinamide ascorbate, riboflavin phosphate, boron citrate (CHILDREN'S MULTIVITAMIN) from unknown date for unknown indication and unknown if ongoing in last 2 weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 07Jun2021 at 02:00 the patient experienced severe pain in Left arm, fever and injection site pain. The patient did not receive any treatment for the event. On 07Jun2021, the patient underwent body temperature and the result was 102.3. The clinical outcome of the event severe pain in Left arm, fever and injection site pain was recovering at the time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained. No further information is expected.
Age: 13.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Body temperature, Pain in extremity, Pyrexia, Vaccination site pain
Clinical narrative: Severe Pain In Left ArmFever Of 102.3Pain At Injection Site; fever; injection site pain; This is a spontaneous report from a contactable consumer, the patient. A 13-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 06Jun2021 at 12:30 (at the age of 13-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 16May2021 at 12:30 hours (at the age of 13-years-old) as a single dose for COVID-19 immunisation. Concomitant medications included montelukast sodium (SINGULAIR) once a day and ascorbic acid, pyridoxal phosphate, biotin, folic acid, colecalciferol, calcium pantothenate, ascorbyl palmitate, cocarboxylase, calcium citrate, tocopheryl acid succinate, calcium ascorbate, magnesium aspartate, betacarotene, manganese, molybdenum, chromium, copper, vanadium, iodine, selenium, mecobalamin, magnesium ascorbate, zinc gluconate, bioflavonoids nos, nicotinamide ascorbate, riboflavin phosphate, boron citrate (CHILDREN'S MULTIVITAMIN) from unknown date for unknown indication and unknown if ongoing in last 2 weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 07Jun2021 at 02:00 the patient experienced severe pain in Left arm, fever and injection site pain. The patient did not receive any treatment for the event. On 07Jun2021, the patient underwent body temperature and the result was 102.3. The clinical outcome of the event severe pain in Left arm, fever and injection site pain was recovering at the time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained. No further information is expected.
Age: 43.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Lymphadenopathy
Clinical narrative: Glands on the left-hand side around collarbone swollen and up.; This is a spontaneous report from a contactable consumer, the patient. A 43-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0187) via an unspecified route of administration in the left arm on 20May2021 at 11:00 (at the age of 43-years-old) as a single dose for COVID-19 immunisation. Medical history included heart ablation due to arrhythmia. The patient had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any medications within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 23May2021 at 00:00, the patient experienced glands on the left-hand side around collar bone swollen and up. The glands were large even after five weeks after the injection, however, they did not hurt. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were taken as a result of the event which included treatment with cooling and glands drainage. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event glands on the left-hand side around collarbone swollen and up was not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 47.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Lymphadenopathy
Clinical narrative: tested positive for covid-19; tested positive for covid-19; This is a spontaneous report from a contactable consumer (patient).  A 48 years old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 intramuscular, administered in Arm Left on 03Mar2021 10:00 (Batch/Lot Number: EL3247) as single dose and dose 2 intramuscular, administered in Arm Right on 24Mar2021 10:00 (Batch/Lot Number: EP6955) as single dose for covid-19 immunisation when 47 years old. Medical history included high blood pressure. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Concomitant medication(s) included amlodipine besilate (NORVASC) taken for an unspecified indication, start and stop date were not reported.  The patient tested positive for covid-19 on 25Jul2021 15:00 (vaccination failure) (medically significant) on 25Jul2021 15:00 with outcome of recovered with sequelae in 2021. The patient underwent lab tests and procedures which included sars-cov-2 test: positive on 27Jul2021 Nasal Swab. The patient reported he received the 2nd dose of Covid-19 vaccine on 24Mar21 and tested positive for Covid-19 on 27Jul21.  The events resulted in Doctor or other healthcare professional office/clinic visit. The patient was not treated due to the event.   No Follow up attempts needed. No further information is expected.
Age: 47.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 test, Vaccination failure
Clinical narrative: tested positive for covid-19; tested positive for covid-19; This is a spontaneous report from a contactable consumer (patient).  A 48 years old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 intramuscular, administered in Arm Left on 03Mar2021 10:00 (Batch/Lot Number: EL3247) as single dose and dose 2 intramuscular, administered in Arm Right on 24Mar2021 10:00 (Batch/Lot Number: EP6955) as single dose for covid-19 immunisation when 47 years old. Medical history included high blood pressure. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Concomitant medication(s) included amlodipine besilate (NORVASC) taken for an unspecified indication, start and stop date were not reported.  The patient tested positive for covid-19 on 25Jul2021 15:00 (vaccination failure) (medically significant) on 25Jul2021 15:00 with outcome of recovered with sequelae in 2021. The patient underwent lab tests and procedures which included sars-cov-2 test: positive on 27Jul2021 Nasal Swab. The patient reported he received the 2nd dose of Covid-19 vaccine on 24Mar21 and tested positive for Covid-19 on 27Jul21.  The events resulted in Doctor or other healthcare professional office/clinic visit. The patient was not treated due to the event.   No Follow up attempts needed. No further information is expected.
Age: 47.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Bacterial test negative, Blood test normal, Chest pain, Dizziness, Electrocardiogram normal
Clinical narrative: Prolonged ongoing low grade fever (99-100) since vaccine 3 weeks ago.; Also c/o malaise, occasional headache and body aches.; Also c/o malaise, occasional headache and body aches.; body aches; This is a spontaneous report from a contactable other HCP (nurse). A 47-years-old non-pregnant female patient started to receive BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EW0178) on 19May2021, (age at vaccination: 47 years) dose 1, single for Covid-19 immunisation. The patient's medical history and concomitant medications were not reported. Patient had no covid prior vaccination. Patient had prolonged ongoing low-grade fever (99-100) since vaccine 3 weeks ago and also c/o malaise, occasional headache and body aches, all from 20May2021. Concerned because symptoms have not resolved, and it's been 3 weeks. Patient is taking Tylenol and Ibuprofen and is staying very well hydrated. Covid tested post vaccination and results were negative. The outcome of the events was not resolved.  Follow-Up (14Jul2021): Follow-up attempts are completed. No further information is expected.
Age: 47.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Fatigue, Fibrin D dimer normal, Headache, Oral discomfort, Pain
Clinical narrative: Prolonged ongoing low grade fever (99-100) since vaccine 3 weeks ago.; Also c/o malaise, occasional headache and body aches.; Also c/o malaise, occasional headache and body aches.; body aches; This is a spontaneous report from a contactable other HCP (nurse). A 47-years-old non-pregnant female patient started to receive BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EW0178) on 19May2021, (age at vaccination: 47 years) dose 1, single for Covid-19 immunisation. The patient's medical history and concomitant medications were not reported. Patient had no covid prior vaccination. Patient had prolonged ongoing low-grade fever (99-100) since vaccine 3 weeks ago and also c/o malaise, occasional headache and body aches, all from 20May2021. Concerned because symptoms have not resolved, and it's been 3 weeks. Patient is taking Tylenol and Ibuprofen and is staying very well hydrated. Covid tested post vaccination and results were negative. The outcome of the events was not resolved.  Follow-Up (14Jul2021): Follow-up attempts are completed. No further information is expected.
Age: 47.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pain in extremity, Pyrexia, Throat tightness
Clinical narrative: Prolonged ongoing low grade fever (99-100) since vaccine 3 weeks ago.; Also c/o malaise, occasional headache and body aches.; Also c/o malaise, occasional headache and body aches.; body aches; This is a spontaneous report from a contactable other HCP (nurse). A 47-years-old non-pregnant female patient started to receive BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EW0178) on 19May2021, (age at vaccination: 47 years) dose 1, single for Covid-19 immunisation. The patient's medical history and concomitant medications were not reported. Patient had no covid prior vaccination. Patient had prolonged ongoing low-grade fever (99-100) since vaccine 3 weeks ago and also c/o malaise, occasional headache and body aches, all from 20May2021. Concerned because symptoms have not resolved, and it's been 3 weeks. Patient is taking Tylenol and Ibuprofen and is staying very well hydrated. Covid tested post vaccination and results were negative. The outcome of the events was not resolved.  Follow-Up (14Jul2021): Follow-up attempts are completed. No further information is expected.
Age: 47.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Body temperature, Headache, Malaise, Pain, Pyrexia
Clinical narrative: Prolonged ongoing low grade fever (99-100) since vaccine 3 weeks ago.; Also c/o malaise, occasional headache and body aches.; Also c/o malaise, occasional headache and body aches.; body aches; This is a spontaneous report from a contactable other HCP (nurse). A 47-years-old non-pregnant female patient started to receive BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EW0178) on 19May2021, (age at vaccination: 47 years) dose 1, single for Covid-19 immunisation. The patient's medical history and concomitant medications were not reported. Patient had no covid prior vaccination. Patient had prolonged ongoing low-grade fever (99-100) since vaccine 3 weeks ago and also c/o malaise, occasional headache and body aches, all from 20May2021. Concerned because symptoms have not resolved, and it's been 3 weeks. Patient is taking Tylenol and Ibuprofen and is staying very well hydrated. Covid tested post vaccination and results were negative. The outcome of the events was not resolved.  Follow-Up (14Jul2021): Follow-up attempts are completed. No further information is expected.
Age: 47.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: SARS-CoV-2 antibody test
Clinical narrative: Prolonged ongoing low grade fever (99-100) since vaccine 3 weeks ago.; Also c/o malaise, occasional headache and body aches.; Also c/o malaise, occasional headache and body aches.; body aches; This is a spontaneous report from a contactable other HCP (nurse). A 47-years-old non-pregnant female patient started to receive BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EW0178) on 19May2021, (age at vaccination: 47 years) dose 1, single for Covid-19 immunisation. The patient's medical history and concomitant medications were not reported. Patient had no covid prior vaccination. Patient had prolonged ongoing low-grade fever (99-100) since vaccine 3 weeks ago and also c/o malaise, occasional headache and body aches, all from 20May2021. Concerned because symptoms have not resolved, and it's been 3 weeks. Patient is taking Tylenol and Ibuprofen and is staying very well hydrated. Covid tested post vaccination and results were negative. The outcome of the events was not resolved.  Follow-Up (14Jul2021): Follow-up attempts are completed. No further information is expected.
Age: 61.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Dizziness, Nausea, Vertigo, Vision blurred
Clinical narrative: Dizziness/ light headed; Mild nausea; This is a spontaneous report from a contactable consumer, the patient. A 61-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left upper arm on 01Jun2021 at 15:45 (at the age of 61-years-old) as a single dose for COVID-19 immunisation. The patients' medical history was reported as none. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any medication within two weeks prior to the vaccination. The patient did not receive any other vaccine within four weeks prior to the COVID-19 vaccination. On 04Jun2021 at 7:00, the patient experienced dizziness, light headed and mild nausea. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events dizziness, light headed and mild nausea were resolving at the time of this report.   The batch/lot number for BNT162b2 was not provided and will be requested during follow up.
Age: 61.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Dizziness, Nausea
Clinical narrative: Dizziness/ light headed; Mild nausea; This is a spontaneous report from a contactable consumer, the patient. A 61-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left upper arm on 01Jun2021 at 15:45 (at the age of 61-years-old) as a single dose for COVID-19 immunisation. The patients' medical history was reported as none. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any medication within two weeks prior to the vaccination. The patient did not receive any other vaccine within four weeks prior to the COVID-19 vaccination. On 04Jun2021 at 7:00, the patient experienced dizziness, light headed and mild nausea. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events dizziness, light headed and mild nausea were resolving at the time of this report.   The batch/lot number for BNT162b2 was not provided and will be requested during follow up.
Age: 25.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Bronchitis, Fatigue, Headache, Laboratory test, Pyrexia
Clinical narrative: Low grade fever of 99.4 for the last 3+ weeks;; Headache; Body sore; Fatigue; This is a spontaneous report from a contactable consumer, the patient. A 25-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EV6208) via an unspecified route of administration in the left arm on 14Mar2021 at 15:15 (at the age of 25-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Patient had no known allergies. Concomitant medications included azithromycin (MANUFACTURER UNKNOWN), ibuprofen (IBUPRIN), naproxen sodium (ALEVE) all from an unknown date for an unspecified indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 19Mar2021, the patient experienced low grade fever of 99.4 for the last 3+ weeks, headache, body sore and fatigue. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of the events and included treatment with Azithromycin, Ibuprofen, ALEVE. On an unknown date, the patient underwent blood tests and the result was Unknown. On an unknown date, the patient underwent urine test and the result was Unknown. On 19Mar2021, the patient underwent Body temperature and the result was 99.4 (UNSPECIFIED UNITS). On 28Mar2021, the patient underwent quick response test (Nasal swab) and the result was negative. The clinical outcome of the events low grade fever of 99.4 for the last 3+ weeks, headache, body sore and fatigue was not recovered.  No follow-up attempts are needed. No further information is expected.
Age: 25.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: SARS-CoV-2 test negative
Clinical narrative: Low grade fever of 99.4 for the last 3+ weeks;; Headache; Body sore; Fatigue; This is a spontaneous report from a contactable consumer, the patient. A 25-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EV6208) via an unspecified route of administration in the left arm on 14Mar2021 at 15:15 (at the age of 25-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Patient had no known allergies. Concomitant medications included azithromycin (MANUFACTURER UNKNOWN), ibuprofen (IBUPRIN), naproxen sodium (ALEVE) all from an unknown date for an unspecified indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 19Mar2021, the patient experienced low grade fever of 99.4 for the last 3+ weeks, headache, body sore and fatigue. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of the events and included treatment with Azithromycin, Ibuprofen, ALEVE. On an unknown date, the patient underwent blood tests and the result was Unknown. On an unknown date, the patient underwent urine test and the result was Unknown. On 19Mar2021, the patient underwent Body temperature and the result was 99.4 (UNSPECIFIED UNITS). On 28Mar2021, the patient underwent quick response test (Nasal swab) and the result was negative. The clinical outcome of the events low grade fever of 99.4 for the last 3+ weeks, headache, body sore and fatigue was not recovered.  No follow-up attempts are needed. No further information is expected.
Age: 25.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood test, Body temperature, Fatigue, Headache, Pain
Clinical narrative: Low grade fever of 99.4 for the last 3+ weeks;; Headache; Body sore; Fatigue; This is a spontaneous report from a contactable consumer, the patient. A 25-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EV6208) via an unspecified route of administration in the left arm on 14Mar2021 at 15:15 (at the age of 25-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Patient had no known allergies. Concomitant medications included azithromycin (MANUFACTURER UNKNOWN), ibuprofen (IBUPRIN), naproxen sodium (ALEVE) all from an unknown date for an unspecified indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 19Mar2021, the patient experienced low grade fever of 99.4 for the last 3+ weeks, headache, body sore and fatigue. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of the events and included treatment with Azithromycin, Ibuprofen, ALEVE. On an unknown date, the patient underwent blood tests and the result was Unknown. On an unknown date, the patient underwent urine test and the result was Unknown. On 19Mar2021, the patient underwent Body temperature and the result was 99.4 (UNSPECIFIED UNITS). On 28Mar2021, the patient underwent quick response test (Nasal swab) and the result was negative. The clinical outcome of the events low grade fever of 99.4 for the last 3+ weeks, headache, body sore and fatigue was not recovered.  No follow-up attempts are needed. No further information is expected.
Age: 25.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pyrexia, SARS-CoV-2 test, Urine analysis
Clinical narrative: Low grade fever of 99.4 for the last 3+ weeks;; Headache; Body sore; Fatigue; This is a spontaneous report from a contactable consumer, the patient. A 25-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EV6208) via an unspecified route of administration in the left arm on 14Mar2021 at 15:15 (at the age of 25-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Patient had no known allergies. Concomitant medications included azithromycin (MANUFACTURER UNKNOWN), ibuprofen (IBUPRIN), naproxen sodium (ALEVE) all from an unknown date for an unspecified indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 19Mar2021, the patient experienced low grade fever of 99.4 for the last 3+ weeks, headache, body sore and fatigue. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of the events and included treatment with Azithromycin, Ibuprofen, ALEVE. On an unknown date, the patient underwent blood tests and the result was Unknown. On an unknown date, the patient underwent urine test and the result was Unknown. On 19Mar2021, the patient underwent Body temperature and the result was 99.4 (UNSPECIFIED UNITS). On 28Mar2021, the patient underwent quick response test (Nasal swab) and the result was negative. The clinical outcome of the events low grade fever of 99.4 for the last 3+ weeks, headache, body sore and fatigue was not recovered.  No follow-up attempts are needed. No further information is expected.
Age: 56.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Lymphadenopathy, Vision blurred, Visual impairment
Clinical narrative: Since the 2nd dose of the pfizer vaccine, the patient  vision had changed; The patient cannot see the prescription through eyeglasses, and had trouble reading up close material, it was blurry; This is a spontaneous report from a contactable consumer, the patient. A 56-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an unspecified route of administration in the left arm on 08Apr2021 at 12:30 (at the age of 56-year-old) as a single dose for COVID-19 immunisation. Medical history included type 2 diabetes mellitus and blood pressure high. It was unknown whether the patient had allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included metformin (MANUFACTURER UNKNOWN); pioglitazone (MANUFACTURER UNKNOWN); acetylsalicylic acid (BAYER ASPIRIN);  iron (MANUFACTURER UNKNOWN); HYDR; all were taken for unspecified indication since unspecified date within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 10Apr2021 at 10:00, since the 2nd dose of the Pfizer vaccine, the patient vision had changed, the patient cannot see the prescription through eyeglasses, and had trouble reading up close material, it was blurry. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the adverse event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event vision had changed since the 2nd dose of the Pfizer vaccine, the patient cannot see the prescription through eyeglasses and had trouble reading up close material and it was blurry were not recovered at the time of this report.    No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 56.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Vision blurred, Visual impairment
Clinical narrative: Since the 2nd dose of the pfizer vaccine, the patient  vision had changed; The patient cannot see the prescription through eyeglasses, and had trouble reading up close material, it was blurry; This is a spontaneous report from a contactable consumer, the patient. A 56-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an unspecified route of administration in the left arm on 08Apr2021 at 12:30 (at the age of 56-year-old) as a single dose for COVID-19 immunisation. Medical history included type 2 diabetes mellitus and blood pressure high. It was unknown whether the patient had allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included metformin (MANUFACTURER UNKNOWN); pioglitazone (MANUFACTURER UNKNOWN); acetylsalicylic acid (BAYER ASPIRIN);  iron (MANUFACTURER UNKNOWN); HYDR; all were taken for unspecified indication since unspecified date within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 10Apr2021 at 10:00, since the 2nd dose of the Pfizer vaccine, the patient vision had changed, the patient cannot see the prescription through eyeglasses, and had trouble reading up close material, it was blurry. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the adverse event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event vision had changed since the 2nd dose of the Pfizer vaccine, the patient cannot see the prescription through eyeglasses and had trouble reading up close material and it was blurry were not recovered at the time of this report.    No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 62.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Retinal operation, Retinal tear, Visual impairment, Vitreous haemorrhage
Clinical narrative: Blurred vision on 1 eye, can't see well.; This is a spontaneous report from a contactable consumer, the patient. A 62-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 14Apr2021 at 09:30 (at the age of 62-year-old) as a single dose for COVID-19 immunisation. Medical history of the patient was reported as none. Concomitant medications included glucosamine (MANUFACTURER UNKNOWN), vitis vinifera, reynoutria japonica (RESVERATROL), prasterone (DHEA) and pterostilbene (MANUFACTURER UNKNOWN) for an unknown indication on an unknown date. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 14Apr2021 at 17:00, the patient experienced blurred vision on 1 eye, can't see well. Therapeutic measures were not taken as a result of these events. The adverse events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event blurred vision on 1 eye, can't see well was unknown at the time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 62.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Vision blurred
Clinical narrative: Blurred vision on 1 eye, can't see well.; This is a spontaneous report from a contactable consumer, the patient. A 62-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 14Apr2021 at 09:30 (at the age of 62-year-old) as a single dose for COVID-19 immunisation. Medical history of the patient was reported as none. Concomitant medications included glucosamine (MANUFACTURER UNKNOWN), vitis vinifera, reynoutria japonica (RESVERATROL), prasterone (DHEA) and pterostilbene (MANUFACTURER UNKNOWN) for an unknown indication on an unknown date. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 14Apr2021 at 17:00, the patient experienced blurred vision on 1 eye, can't see well. Therapeutic measures were not taken as a result of these events. The adverse events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event blurred vision on 1 eye, can't see well was unknown at the time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 56.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Discomfort, Fatigue, Muscle swelling, Pain, Pain in extremity
Clinical narrative: after second shot followed by itchy rash forming on both forearms and spreading over several days to shoulders, neck and legs.; Massive headache; night sweats; body aches; pains; This is a spontaneous report from a contactable consumer, the patient. A 56-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 28Apr2021 at 16:45(at the age of 56-year-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. Concomitant medications included vitamin d nos (VITAMIN D) and magnesium sulfate (MAGNESIUM), all from unknown dates and for unknown indications. The patient previously received first dose of BNT162b2(PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 07Apr2021 at 16:45(at the age of 56-year-old) as a single dose for COVID-19immunisation. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 10May2021 at 02:00, the patient experienced massive headache, night sweats, body ache and pains. On 11May2021, the patient experienced  itchy rash forming on both forearms and spreading over several days to shoulders, neck and legs. The adverse events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of reported events which included treatment with herbal supplements to relieve effects. The clinical outcome of the event massive headache, night sweats, body aches, pains and itchy rash on both forearms, shoulders, neck and legs was recovering at the time of this report   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 56.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Rash pruritic, Rash vesicular
Clinical narrative: after second shot followed by itchy rash forming on both forearms and spreading over several days to shoulders, neck and legs.; Massive headache; night sweats; body aches; pains; This is a spontaneous report from a contactable consumer, the patient. A 56-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 28Apr2021 at 16:45(at the age of 56-year-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. Concomitant medications included vitamin d nos (VITAMIN D) and magnesium sulfate (MAGNESIUM), all from unknown dates and for unknown indications. The patient previously received first dose of BNT162b2(PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 07Apr2021 at 16:45(at the age of 56-year-old) as a single dose for COVID-19immunisation. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 10May2021 at 02:00, the patient experienced massive headache, night sweats, body ache and pains. On 11May2021, the patient experienced  itchy rash forming on both forearms and spreading over several days to shoulders, neck and legs. The adverse events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of reported events which included treatment with herbal supplements to relieve effects. The clinical outcome of the event massive headache, night sweats, body aches, pains and itchy rash on both forearms, shoulders, neck and legs was recovering at the time of this report   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 56.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Headache, Night sweats, Pain, Rash pruritic
Clinical narrative: after second shot followed by itchy rash forming on both forearms and spreading over several days to shoulders, neck and legs.; Massive headache; night sweats; body aches; pains; This is a spontaneous report from a contactable consumer, the patient. A 56-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 28Apr2021 at 16:45(at the age of 56-year-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. Concomitant medications included vitamin d nos (VITAMIN D) and magnesium sulfate (MAGNESIUM), all from unknown dates and for unknown indications. The patient previously received first dose of BNT162b2(PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 07Apr2021 at 16:45(at the age of 56-year-old) as a single dose for COVID-19immunisation. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 10May2021 at 02:00, the patient experienced massive headache, night sweats, body ache and pains. On 11May2021, the patient experienced  itchy rash forming on both forearms and spreading over several days to shoulders, neck and legs. The adverse events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of reported events which included treatment with herbal supplements to relieve effects. The clinical outcome of the event massive headache, night sweats, body aches, pains and itchy rash on both forearms, shoulders, neck and legs was recovering at the time of this report   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 70.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Therapeutic response unexpected
Clinical narrative: her eyes are repaired/  I wonder if it has somehow repaired my cones/rods. Also wondering if it has helped my blood pressure; This is a spontaneous report from a contactable consumer (patient). A 70-year-old female patient received BNT162B2 (COMIRNATY;,Solution for injection,), dose 1 via an unspecified route of administration on 02Mar2021 (Batch/Lot Number: EN6198) as dose 1 (at the age of 70 year), single, dose 2 via an unspecified route of administration on 23Mar2021 (Batch/Lot number was not reported) as dose 2, single (at the age of 70 year) for COVID-19 immunisation. Medical history included myocardial infarction. The patient's concomitant medications were not reported. On an unspecified date in 2021, Patient had the Pfizer covid shot and now patient seeing colors brilliantly. Patient knew that's not something you're concerned with, but patient wonder if it has somehow repaired my cones/rods. Also wondering if it has helped my blood pressure, of it was having started using progesterone. Prior to this, Patient had very negative side effects from cardiac meds, so patient started progesterone and it seems to be helping. But patient wonder if the shot was somehow fixing things. Patient had an EKG abnormality, and it was now good after patient received the vaccine. Patient said all her arteries were normal. Patient added her eyes are repaired. Patient said she's sensitive to blue lights and they seem a little yellow to her now. Patient sated in the 1990s, patient had no melanin and things were pale. Patient sated that she noticed back then in exercise class, after 30 minutes patient stated could see dark and light but now this time the colors were all light and bright. Patient sated she was not sure if it fixed the rods and cones that were responsible for perception of color or what. Patient sated that she didn't know if it was the Covid vaccine or if it was because she stopped taking her blood pressure medication because it can cause stiffness and difficulty walking. Patient sated she read progesterone cream helps with blood pressure and it does for her. Patient sated it could reversed heart damage from the Covid vaccine, but she had a flipped p wave and they said she had a heart attack many years ago. Patient sated after both doses of the Covid vaccines, patient has an upright p wave. Patient sated she didn't know if the EKG was just positional or what. Patient sated she wonders if this stuff was repairing, not just like a vaccine like the polio, chicken pox, or mumps. Patient sated she was not positive but she doesn't think she was as photosensitive, so that was beneficial. Patient sated she knew so many people who were so anti Covid vaccine and if she touched them they freak out and say she was going to get metal in their body.
Age: 70.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Electrocardiogram abnormal, Therapeutic response unexpected
Clinical narrative: her eyes are repaired/  I wonder if it has somehow repaired my cones/rods. Also wondering if it has helped my blood pressure; This is a spontaneous report from a contactable consumer (patient). A 70-year-old female patient received BNT162B2 (COMIRNATY;,Solution for injection,), dose 1 via an unspecified route of administration on 02Mar2021 (Batch/Lot Number: EN6198) as dose 1 (at the age of 70 year), single, dose 2 via an unspecified route of administration on 23Mar2021 (Batch/Lot number was not reported) as dose 2, single (at the age of 70 year) for COVID-19 immunisation. Medical history included myocardial infarction. The patient's concomitant medications were not reported. On an unspecified date in 2021, Patient had the Pfizer covid shot and now patient seeing colors brilliantly. Patient knew that's not something you're concerned with, but patient wonder if it has somehow repaired my cones/rods. Also wondering if it has helped my blood pressure, of it was having started using progesterone. Prior to this, Patient had very negative side effects from cardiac meds, so patient started progesterone and it seems to be helping. But patient wonder if the shot was somehow fixing things. Patient had an EKG abnormality, and it was now good after patient received the vaccine. Patient said all her arteries were normal. Patient added her eyes are repaired. Patient said she's sensitive to blue lights and they seem a little yellow to her now. Patient sated in the 1990s, patient had no melanin and things were pale. Patient sated that she noticed back then in exercise class, after 30 minutes patient stated could see dark and light but now this time the colors were all light and bright. Patient sated she was not sure if it fixed the rods and cones that were responsible for perception of color or what. Patient sated that she didn't know if it was the Covid vaccine or if it was because she stopped taking her blood pressure medication because it can cause stiffness and difficulty walking. Patient sated she read progesterone cream helps with blood pressure and it does for her. Patient sated it could reversed heart damage from the Covid vaccine, but she had a flipped p wave and they said she had a heart attack many years ago. Patient sated after both doses of the Covid vaccines, patient has an upright p wave. Patient sated she didn't know if the EKG was just positional or what. Patient sated she wonders if this stuff was repairing, not just like a vaccine like the polio, chicken pox, or mumps. Patient sated she was not positive but she doesn't think she was as photosensitive, so that was beneficial. Patient sated she knew so many people who were so anti Covid vaccine and if she touched them they freak out and say she was going to get metal in their body.
Age: 29.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Injection site discolouration, Injection site pain, Injection site swelling, Injection site vesicles
Clinical narrative: Discoloration on and under the spot on the left arm,; blister that keeps getting bigger with pus in it.; This is a spontaneous report from a contactable consumer, the patient. A 29-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 16Jun2021 at 14:30 (at the age of 29-years-old) as a single dose for COVID-19 immunisation. Medical history included none. Patient had no known allergies. Concomitant medications included loratadine (CLARITIN) from an unknown date for an unspecified indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 17Jun2021 at 00:00, the patient experienced discoloration on and under the spot on the left arm, blister that kept getting bigger with pus in it. The events resulted in doctor or other healthcare professional office/clinic visit. The patient did not receive any treatment for the events. The clinical outcome of the events discoloration on and under the spot on the left arm, blister that kept getting bigger with pus in it was unknown.  The lot number for BNT162b2 was not provided and will be requested during follow up.